This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation
Orphanet Journal of Rare Diseases Open Access 29 October 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2006; 12: 138–151.
Sanders JE, Hoffmeister PA, Woolfrey AE, Carpenter PA, Storer BE, Storb RF et al. Thyroid function following hematopoietic cell transplantation in children: 30 years’ experience. Blood 2009; 113: 306–308.
Berger C, Le-Gallo B, Donadieu J, Richard O, Devergie A, Galambrun C et al. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant. 2005; 35: 991–995.
Jung MH, Cho KS, Lee JW, Chung NG, Cho B, Suh BK et al. Endocrine complications after hematopoietic stem cell transplantation during childhood and adolescence. J Korean Med Sci 2009; 24: 1071–1077.
Somali M, Mpatakoias V, Avramides A, Sakellari I, Smias Ch, Anagnostopoulos A et al. Thyroid dysfunction in adult long-term survivors after hematopoietic stem-cell transplantation (HSCT). Horm Metab Res 2005; 37: 494–499.
Tauchmanová L, Selleri C, Rosa GD, Pagano L, Orio F, Lombardi G et al. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer 2002; 95: 1076–1084.
Savani BN, Koklanaris EK, Le Q, Shenoy A, Goodman S, Barrett AJ . Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant 2009; 15: 377–381.
Al-Hazzouri A, Cao Q, Burns LJ, Weisdorf DJ, Majhail NS . Similar risks for hypothyroidism after allogeneic hematopoietic cell transplantation using TBI-based myeloablative and reduced-intensity conditioning regimen. Bone Marrow Transplant 2009; 43: 949–951.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Sánchez-Ortega, I., Canals, C., Peralta, T. et al. Thyroid dysfunction in adult patients late after autologous and allogeneic blood and marrow transplantation. Bone Marrow Transplant 47, 296–298 (2012). https://doi.org/10.1038/bmt.2011.54
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2011.54
This article is cited by
-
Impact of allogeneic stem cell transplantation on thyroid function
Journal of Endocrinological Investigation (2023)
-
Thyroid dysfunction in adult hematopoietic cell transplant survivors: risks and outcomes
Bone Marrow Transplantation (2018)
-
Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation
Orphanet Journal of Rare Diseases (2014)